From: Evaluation of miRNA-21 and CA-125 as a promising diagnostic biomarker in patients with ovarian cancer
Patients (n = 50)
Controls (n = 50)
p
miR-21
Mean ± SD
5.54 ± 1.87
1.1 ± 0.43
< 0.001
CA125
Median
478
44
Range
19–1325
10–477